Valuation : Biosynex

Market Cap 1.7Cr 1.98Cr 1.6Cr 1.46Cr 2.73Cr 187.79Cr 2.74Cr 19Cr 7.34Cr 96Cr 7.44Cr 7.28Cr 305.44Cr P/E 2024
-0.43x
P/E 2025 -0.19x
Enterprise Value 7.02Cr 8.17Cr 6.61Cr 6.03Cr 11Cr 774.27Cr 11Cr 78Cr 30Cr 395.75Cr 31Cr 30Cr 1.26TCr EV / Sales 2024
0.71x
EV / Sales 2025 0.68x
Free-Float
40.35%
Yield 2024 *
-
Yield 2025 -
1 day-0.43%
1 week+4.55%
Current month+2.45%
1 month+1.10%
3 months-2.13%
6 months+6.48%
Current year+54.36%
1 week 0.86
Extreme 0.86
1.04
1 month 0.81
Extreme 0.808
1.04
Current year 0.56
Extreme 0.564
1.57
1 year 0.46
Extreme 0.455
1.57
3 years 0.46
Extreme 0.455
10.8
5 years 0.46
Extreme 0.455
28.78
10 years 0.46
Extreme 0.455
30.38
Manager TitleAgeSince
Chief Executive Officer 71 24/06/2015
Chief Tech/Sci/R&D Officer 63 01/01/2015
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member 63 24/06/2015
Director/Board Member - 24/06/2015
Chairman 71 24/06/2015
Date Insider Type Main position Quantity % Market Cap. Importance
15/02/23 Buy

Director

2,500 0.0244%
15/02/23 Buy

Director

2,500 0.0244%
28/02/22 Buy

Chief Executive Officer

2,000 0.0180%
Change 5-day change 1-year change 3-year change Capi.($)
-0.43%+4.55%-22.03%-91.43% 1.98Cr
-0.27%-2.09%+167.56%+377.40% 2.16TCr
-0.28%-4.96%-37.19%-21.97% 986.24Cr
+4.71%+9.37%+370.93%+38.51% 854.71Cr
-1.00%+0.16%-28.70% - 701.4Cr
-0.52%-0.44%+87.28%+51.27% 655.6Cr
-2.12%-1.68%-26.90%-19.34% 583.58Cr
+0.24%-3.38%-10.04%-20.51% 423.84Cr
-3.51%-2.89%+70.20%+84.91% 419.83Cr
-0.86%-2.60%-23.91%-29.78% 274.4Cr
Average -0.40%-0.28%+54.72%+41.01% 706.19Cr
Weighted average by Cap. -0.10%-0.70%+96.62%+136.39%

Financials

2024 2025
Net sales 10Cr 12Cr 9.52Cr 8.69Cr 16Cr 1.12TCr 16Cr 112.77Cr 44Cr 570.16Cr 44Cr 43Cr 1.81TCr 9.52Cr 11Cr 8.96Cr 8.17Cr 15Cr 1.05TCr 15Cr 106.11Cr 41Cr 536.49Cr 42Cr 41Cr 1.71TCr
Net income -4.33Cr -5.04Cr -4.08Cr -3.72Cr -6.94Cr -477.79Cr -6.98Cr -48Cr -19Cr -244.21Cr -19Cr -19Cr -777.13Cr -5.82Cr -6.77Cr -5.48Cr -5Cr -9.33Cr -641.99Cr -9.38Cr -65Cr -25Cr -328.14Cr -25Cr -25Cr -1.04TCr
Net Debt 5.29Cr 6.16Cr 4.98Cr 4.54Cr 8.48Cr 583.68Cr 8.53Cr 59Cr 23Cr 298.34Cr 23Cr 23Cr 949.38Cr 5.32Cr 6.19Cr 5Cr 4.57Cr 8.52Cr 586.49Cr 8.57Cr 59Cr 23Cr 299.77Cr 23Cr 23Cr 953.93Cr
Logo Biosynex
Biosynex specializes in the research, development and manufacturing of fast diagnosis tests on membrane support for health professionals (biologists, clinicians, nurses and midwives). Products are used in the tropical diseases, autoimmune diseases, emergency markers and Infectious diseases fields. The company's activity is organized around 5 areas: - manufacturing of diagnosis tests for own account; - sale of diagnosis tests supplied by other manufacturers of semi-finished products; - research and development services for third party; - sale of licenses; - sale of biological reagents.
Employees
397
Date Price Change Volume
09/26/09 0.9200 -0.43% 7,885
08/26/08 €0.9240 -2.74% 83,595
07/26/07 €0.9500 +6.50% 2,28,125
04/26/04 €0.8920 +1.13% 1,246
03/26/03 €0.8820 +0.23% 2,792
  1. Stock Market
  2. Stocks
  3. ALBIO Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!